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ABSTRACT
The highly abundant N6-methyladenosine (m6A) RNA
modification affects most aspects of mRNA function,
yet the precise function of the rarer 5-methylcytidine
(m5C) remains largely unknown. Here, we map
m5C in the human transcriptome using methylation-
dependent individual-nucleotide resolution cross-
linking and immunoprecipitation (miCLIP) combined
with RNA bisulfite sequencing. We identify NSUN6
as a methyltransferase with strong substrate speci-
ficity towards mRNA. NSUN6 primarily targeted three
prime untranslated regions (3′UTR) at the consen-
sus sequence motif CTCCA, located in loops of hair-
pin structures. Knockout and rescue experiments re-
vealed enhanced mRNA and translation levels when
NSUN6-targeted mRNAs were methylated. Ribosome
profiling further demonstrated that NSUN6-specific
methylation correlated with translation termination.
While NSUN6 was dispensable for mouse embryonic
development, it was down-regulated in human tu-
mours and high expression of NSUN6 indicated bet-
ter patient outcome of certain cancer types. In sum-
mary, our study identifies NSUN6 as a methyltrans-
ferase targeting mRNA, potentially as part of a quality
control mechanism involved in translation termina-
tion fidelity.
INTRODUCTION
Over 170 known RNA modifications extensively increase
the functional diversity of RNA molecules (1). Accord-
ingly, RNA modifications emerged as an important addi-
tional regulatory layer of gene expression programs and
are often required for normal development (2). Recent ad-
vances in detection technology, mostly associated with high-
throughput sequencing, have revealed how RNA modifi-
cations influence many stages of RNA metabolism, and
thereby effect diverse biological processes including cell fate
decisions, immune responses, and tumorigenesis (3–5).
One of the best-studied modifications is N6-
methyladenosine (m6A), the most abundant inter-
nal mRNA modification that controls gene expres-
sion (6). The prevalence and function of other rarer
mRNA modifications such as N1-methyladenosine
(m1A), N6,2′-O-dimethyladenosine (m6Am), m5C, 5-
hydroxymethylcytosine (hm5C), and pseudouridine ()
are less well-characterised and often somewhat contro-
versial (7). One of the most disputed modifications in
mRNA is m5C as current conventional detection methods
are associated with high background levels, making this
low-abundance modification particularly challenging to
define (8,9). Furthermore, the total levels of m5C in mRNA
varies between tissues (10). Nevertheless, NSUN2, a m5C
RNA methyltransferase mainly targeting tRNAs, has
consistently been linked to mRNA methylation (11–15).
NSUN2 is one of eight evolutionary conserved m5C
RNA methylases (NSUN1–7 and DNMT2) (2). Of these,
NSUN2, 3, 6 and DNMT2 have all been shown to methylate
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†The authors wish it to be known that, in their opinion, the first two authors should be regarded as Joint First Authors.
C© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which
permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Nucleic Acids Research, 2021, Vol. 49, No. 2 1007
tRNAs, yet in a non-overlapping and site-specific manner
(15–20). NSUN2 is however the only enzyme with a broader
substrate-specificity, methylating the majority of expressed
tRNA, other abundant non-coding RNAs and a small num-
ber of mRNAs (11–15,21).
Here, we map NSUN6-dependent m5C sites in RNAs
in the human transcriptome using our recently developed
miCLIP method (12,22). Unexpectedly, we find that most
sites located to protein coding RNAs within the consen-
sus sequence motif CTCCA. NSUN6-specific sites were en-
riched in the 3′UTR and marked translation termination.
RNA bisulfite (BS) sequencing confirmed m5C sites in mR-
NAs that were lost in knockout cells and rescued by over-
expressing the NSUN6 protein. NSUN6-targeted mRNAs
were more abundant with higher translation rates. NSUN6
was dispensable for mouse embryonic development. How-
ever, NSUN6-expression levels were down-regulated in tu-
mours when compared to normal tissues, and high NSUN6
positively correlated with patient survival rate. Together,
our study shows for the first time that NSUN6 mediates site-
specific deposition of m5C in mRNA, potentially as part of
a novel translation quality control mechanism.
MATERIALS AND METHODS
Cell culture
The human embryonic stem cell (hESC) line Hues9 (H9)
was obtained from the Wicell Research Institute (Madison,
WI) and maintained in Essential 8 media (Thermo Fisher
Scientific) on hESC-Qualified Matrigel (Corning) coated
plates. Media was refreshed daily and the cultures were dis-
sociated in clumps every 4 days using 0.5 mM EDTA in
PBS. In the embryoid bodies experiments, 70% confluent
hESC were dissociated in clumps and seeded on ultra-low
attachment well plates (Corning) maintaining a 1:1 dilution
factor. After plating, hESC were cultured in Essential 6 me-
dia (Thermo Fisher Scientific) plus 10 M rock-inhibitor
(Y-27632) (Stem Cell Technologies Canada) for the first 24
h and for further 7 days in Essential 6 media (Thermo Fisher
Scientific).
HEK293 (HEK) (ATCC) and MBA-MD-231 (ATCC)
cells were grown in DMEM Media (Thermo Fisher Scien-
tific) supplemented with 1mM Glutamax (Thermo Fisher
Scientific), 10% heat inactivated FBS (Thermo Fisher Sci-
entific). All cells were grown at 37◦C, 5% CO2.
Migration assays
NSUN6 was knocked down in MDA-MB-231 using
NSUN6 siRNA pools (siTOOLsBIOTEC) via RNAimax
transfection reagent (Thermo Fisher Scientific), accord-
ing to manufacturer’s instructions. Twenty-four hours post
transfection, NSUN6 and control siRNA treated cells were
cultured for another 24 h in DMEM containing 1% heat in-
activated FBS. On the day of the experiment, 5000 starved
cells were plated onto a Transwell insert (Costar, 8m pores)
in DMEM containing 1% heat inactivated FBS. The plate
well was filled with DMEM containing 10% FBS to pro-
mote migration. After 24 h, Transwell inserts were fixed and
stained with a solution of Crystal Violet in 80% Methanol
for 10 min, followed by three washes in PBS. Non-migratory
cells, on the upper side of the membrane, were removed by
gently swiping with cotton swabs. Cells that migrated to the
lower side of the Transwell were quantified by microscopy
and counted using ImageJ software. At least three represen-
tative images were taken per Transwell filter. Each sample
was tested in quadruplicates.
Generation of NSUN6 knockout, rescue and overexpressing
lines
NSUN6 knockout H9 cells were generated either by us-
ing homology directed recombination (HDR) or by insert-
ing random Indels in response of double strand breaks
(NHEJ). For HDR, we targeted exon 2 of NSUN6 with
wild type Cas9 (pSpCAs9(BB)2A-GFP) plus the recombi-
nation vector pD07 (Genecopoeia) carrying the selection
genes puromycin and eGFP under control of EIF1a pro-
moter and with homology arms on Introns 1 and 2. gRNAs
were designed using the gRNA design software from the
Feng Zhang lab at MIT (Exon2 gRNA1: ATT TTT CAC
ATG TTG TAC TG AGG, Exon2 gRNA2: GAT GAA
CTT CAG AAG GTT TG TGG). Four days after nucleo-
fection with the AMAXA Nucleofector Kit (Lonza), we ap-
plied puromycin selection until we observed the appearance
of green colonies, which were screened for integration of
the recombination cassette and for the presence of NSUN6
exon 2. For NHEJ, we targeted the exon 9 of NSUN6 with
wild type Cas9 (pSpCAs9(BB)2A-GFP) (Exon 9 gRNA:
ATC CAG AAG AAT TCG GTC AA AGG), 3 days af-
ter nucleofection, the targeted cells were sorted and re-
plated at low density in E8 conditioned media. We then
screened by Sanger Sequencing the grown colonies for In-
Dels in NSUN6 exon 9. For generating NSUN6 overex-
pressing H9, NSUN6 CDS was PCR amplified from the
TrueORF pCMV-Entry vector (Origene) and cloned via
Gibson assembly (NEB) into the destination piggybac vec-
tor pBPCAG-cHA-IN (kindly provided by Austin Smith).
This vector and the piggy bac transposase were then nucleo-
fected into H9 using the AMAXA nucleofector kit (Lonza).
Puromycin selection started 4 days following nucleofection
and the surviving clones were screened by qPCR and West-
ern Blot for NSUN6 expression. The NSUN6 knockout
HEK293 cells were generated employing a similar NHEJ-
based methodology, using the guide RNA sequence: CTG
ATG ACA TAC TTC AGT TC. The same overexpression
strategy used in H9 was also adopted to rescue NSUN6 ex-
pression in knockout HEK293 cells.
Luciferase reporter assay
NSUN6 knockout and overexpressing HEK cells were
seeded in a 24-well plate and after 24 h transfected
with either the ANGEL1–3′UTR-luciferase vector
(GeneCopoeia, HmiT006021-MT05) or the control-
luciferase vector (GeneCopoeia, CmiT000001-MT05)
using Lipofectamine2000 according to the manufacturer’s
instruction (Thermo Fisher Scientific). After 48 h, the
medium was collected and the luciferase assay was per-
formed with the Secrete-Pair Dual Luminescence Assay Kit
according to the protocol (Genecopoeia). To quantify the
reporter activity, we first normalized for transfection effi-
ciency using secreted Alkaline Phosphatase (SEAP), which
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is encoded on the same plasmid. Second, we measured the
relative luciferase activity from the reporter containing the
Angel1 3′ UTR sequence compared to the reporter without
the 3′ UTR (CmiT000001-MT05).
Measuring global protein synthesis with OP-puromycin
FaDu cells were reverse transfected with a siPOOL de-
signed against NSUN6 or a scrambled control siPOOL
(siTOOLs Biotech). After 48 or 72 h, cells were treated with
OP-puromycin for an hour. Afterwards, the cells were col-
lected, fixed and permeabilized. Using Click-it chemistry
(Thermo Fisher Scientific), the OP-puromycin containing
peptides were stained with Alexa Fluor 647 and analysed
on a FACSCanto Cell Analyzer (BD Biosciences). Cyclo-
heximide treated cells were used as a control.
Mass spectrometry
NSUN2, NSUN6 and DNMT2 were depleted by transfect-
ing the corresponding siRNA Pools or a Negative Control
siRNA pool (siTOOLsBIOTECH). The transfections were
carried out using Lipofectamine RNAiMAX transfection
reagent (Thermo Fisher Scientific) in six-well plates, accord-
ing to manufacturer’s instructions. The siRNAs were de-
signed to target the transcripts coding for NSUN2 (NCBI
Gene ID: 54888), NSUN6 (NCBI Gene ID: 221078) and
DNMT2 (NCBI Gene ID: 1787). For sample collection,
cells were directly lysed in Trizol (ThermoFisher Scien-
tific) and total RNA was extracted according to the man-
ufacturer’s instruction. mRNA was purified in HEK wild-
type as well as NSUN6 knockout and rescued cells using
DYNAL Dynabeads mRNA purification kit (ThermoFis-
cher Scientific) using half the beads and reagents recom-
mended by the manufacturer. The resulting poly A enriched
RNA was further purified with RiboMinus Eukaryote kit
v2 (ThermoFischer Scientific) according to manufacturer’s
instruction followed by ammonium acetate precipitation.
Mass spectrometry to quantify m5C was performed as de-
scribed previously (10,23).
Generation of the Nsun6 knockout mice
All mice were housed in the Wellcome Trust-Medical Re-
search Council Cambridge Stem Cell Institute Animal
Unit. All mouse husbandry and experiments were carried
out according to the local ethics committee under the terms
of a UK Home Office license P36B3A804 and PPL70/7822.
Two embryonic stem cell lines containing a knockout first
allele (with conditional potential) were obtained from Eu-
MMCR (Nsun6tm1a(EUCOMM)Hmgu). Mice homozygote for
the targeted trap allele was used to analyse Nsun6 total
knockout. Genotyping primers were: Nsun6-forward (AAT
CCA GCA TTC CTG TTG TTC AGC), LoxR (TGA ACT
GAT GGC GAG CTC AGA CC), Nsun6–5′arm-2 (ACA
GTG AGT CAG GTG AGG TGT GCC), and Nsun6-rev
(CAC AAT GAG ACA GCA CCC AG). The LacZ-neo
cassette was used as reporter for Nsun6 RNA expression in
wild-type and Nsun6 total knockout mice. LacZ staining on
whole mounts and sections of embryos was performed as
described previously (24).
RT-qPCR and western blotting
Total RNA was extracted using TRIZOL (Thermo Fisher
Scientific) according to manufacturer instructions. Reverse
transcription was performed using SuperScript III Reverse
Transcriptase (Thermo Fisher Scientific) and random
primers (Promega). Quantitative PCR were run using
TaqMan probes (Thermo Fisher Scientific) for eukaryotic
18S rRNA (X03205.1), MARCKSL1 (Hs00702769 s1),
TRAF7 (Hs00260228 m1), ANGEL1 (Hs00380490 m1),
CALM3 (Hs00968732 g1), BAG6 (Hs00190383 m1),
CUX1 (Hs00738851 m1), TRIMM50 (Hs01390531 m1),
BUB3 (Hs00945687 m1), EEF (Hs00265885 g1), MACF1
(Hs00201468 m1), DLX5 (Hs01573641 mH), DNMT3B
(Hs00171876 m1), FOXD3 (Hs00255287 s1), GATA6
(Hs00232018 m1), HOXA1 (Hs00939046 m1), NANOG
(Hs02387400 g1), POU5F1 (Hs03005111 g1), TDGF1
(Hs02339497 g1).
For protein isolation, cells were first rinsed with PBS
and lysed in ice-cold RIPA buffer (50 mM Tris–HCl
pH 7.4, 1% NP-40, 150 mM NaCl, 0.1% SDS, 0.5%
sodium deoxycholate). RIPA was supplemented with cOm-
plete Mini EDTA-free Protease Inhibitor Cocktail tablets
(11836170001, Roche). Cells were collected using a cell
scraper and the lysates were centrifuged for 15 min at max-
imum speed in a pre-cooled centrifuge at 4◦C, and their su-
pernatant collected and kept on ice. Cell protein lysates were
mixed with NuPAGE LDS Sample Buffer (4X) (NP0007;
Invitrogen) and run on polyacrylamide gels. Proteins were
transferred to a nitrocellulose or PVDF membrane (GE
Healthcare). Membranes were blocked for a minimum of 1
h at room temperature in 5% (w/v) non-fat milk or 5% (w/v)
BSA (A4503–50G; Sigma Aldrich) in TBS-T (1× TBS and
0.1% Tween-20) and then incubated with primary antibody
in blocking solution overnight at 4◦C. Each membrane was
washed three times for 10 min in TBS-T prior to incuba-
tion with the appropriate Horseradish peroxidase (HRP)-
labeled secondary antibody (1:10 000) in TBS-T at room
temperature for 1 h. After washing, the antibodies were de-
tected by using the Amersham ECL Prime Western Blotting
Detection Reagent (RPN2232; GE Healthcare). The pri-
mary antibody was NSUN6 (1:500, 17240-1-AP, Protein-
tech). Anti- -Tubulin (T6557; Sigma Aldrich), Anti-HSP90
(sc-13119; Santa-Cruz) or Ponceau staining served as load-
ing controls.
miCLIP
Full-length cDNA constructs for NSUN6 in the pCMV6-
Entry-Myc vector were obtained from OriGene. Site-
directed mutagenesis to generate the miCLIP-mutants was
performed using the QuikChange II Site-Directed Mutage-
nesis Kit from Agilent as per the manufacturer’s instruc-
tions. To generate the NSUN6 miCLIP mutant, cysteine
326 was mutated to alanine using the following primers:
(forward) GAA TTC TTC TGG ATG CAC CCG CTA
GTG GAA TGG GAC AGA GAC; (reverse) GTC TCT
GTC CCA TTC CAC TAG CGG GTG CAT CCA GAA
GAA TTC. HEK293 cells were transfected with either
NSUN6 wild-type and the miCLIP-mutant construct using
Lipofectamine 2000 (Life Technologies) and harvested 24 h
later.
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The harvested cells were lysed in lysis buffer consisting of
50 mM Tris–HCl pH 7.4, 100 mM NaCl, 1% NP-40, 0.1%
SDS, 0.5% sodium deoxycholate. Lysates were then treated
with high concentration of DNase and low concentration of
RNaseI to partially fragment RNAs. Lysates were cleared
by centrifugation at 13 000 rpm for 15 min at 40◦C and then
incubated with Protein G Dynabeads (Life Technologies)
in the presence of an anti-Myc antibody (9E10, Sigma).
Following stringent washing, 3′ end dephosphorylation was
performed with T4 polynucleotide kinase (New England Bi-
olabs) before addition of a pre-adenylated linker using RNA
ligase (New England Biolabs). 5′ end labelling was then per-
formed using T4 PNK and 32P-ATP before protein–RNA
complexes were eluted and run on denaturing gels. Nitro-
cellulose transfer was performed, and the radioactive sig-
nal was used to dissect nitrocellulose pieces that contained
NSUN6-partially digested RNA complexes. RNA was re-
covered by incubating the nitrocellulose pieces in a buffer
containing Proteinase K and 3.5 M urea. Next, reverse tran-
scription was performed using oligonucleotides contain-
ing two inversely oriented adaptor regions separated by a
BamHI restriction site. cDNAs were size-purified on TBE–
urea gels before being circularized by CircLigase II (Epicen-
tre). Circularised cDNAs were then annealed to an oligonu-
cleotide complementary to the BamHI site and then BamHI
digested. Linearized cDNAs were then PCR-amplified us-
ing primers complementary to the adaptor regions using
25 cycles of PCR. Libraries were then subjected to high-
throughput sequencing using the Illumina HiSeq 2000 plat-
form.
RNA bisulfite conversion and sequencing
Total RNA from H9 wild-type (WT), knockout (KO), over-
expression (OEX) and HEK293 WT, KO and NSUN6 res-
cue (RES) cells was first extracted using Trizol (Thermo
Fisher Scientific) and subsequently treated with DNaseI
(Ambion) and RiboZero (Illumina) to remove contaminat-
ing DNA and ribosomal RNAs. The remaining RNA was
then converted as previously described (15,25). Briefly, 10
g of RNA was resuspended in 10 l of RNAse free wa-
ter and mixed with sodium bisulfite pH 5.0 (42.5 l) and
DNA protection buffer (17.5 l) (EpiTect Bisulfite Kit, Qi-
agen). The deamination reaction was then carried out by
incubating in a thermal cycler for four cycles of 5 min at
70◦C followed by 1 h at 60◦C and then desalted with Mi-
cro Bio-spin 6 chromatography columns (Bio-Rad). RNA
was desulphonated by adding an equal volume of 1 M
Tris (pH 9.0) to the reaction mixture for 1 h at 37◦C,
followed by ethanol precipitation. The bisulfite-converted
RNA quality and concentration were assessed on a Bio-
analyzer 2100 RNA nano-chip (Agilent). About 120 ng of
bisulfite-converted RNA were used to generate Bisulfite-
seq libraries using the TruSeq Small RNA preparation
kit (Illumina). Before library preparation, the fragmented
RNA wasend-repaired with T4 PNK and Spermidine (New
England Biolabs). The size selection step was omitted, as
the bisulfite-converted RNA was sufficiently fragmented by
the previous conversion reaction. First the Illumina RNA
adapters were then ligated, reverse-transcribed at 50◦C for
1 h with SuperScript III and 1 mM of each dNTP (Super-
Script III cDNA synthesis kit, Invitrogen) followed by 18-
cycle PCR amplification.
RNA sequencing and ribosome profiling
Total RNA extraction, ribosome profiling (Ribo-seq) and
libraries for H9 NSUN6 WT and KO cells (at least four
replicates each) were performed as described before (26–28).
The samples were multiplexed and sequenced on the HiSeq
4000 platform (Illumina).
Processing, mapping and quantification of RNA-seq and
Ribo-seq reads
The H9 RNA-seq data was sequenced as paired-end 2 × 150
nt and the HEK RNA-seq data was sequenced as single-end
50 nt. All Ribo-seq data was single-end 50 nt. To process
the data, Trim galore! (https://github.com/FelixKrueger/
TrimGalore) with parameters ‘–stringency 6 -e 0.1’ and ‘–
paired’ for the paired-end data was first used to remove Illu-
mina adapters and to exclude trimmed reads shorter than 20
nt. Alignment was done using Tophat2 (v2.1.0) using an in-
dex with known transcripts (Gencode v23) as guidance and
with novel splice junctions permitted. The RNA-seq reads
were aligned directly to the reference genome (hg38). Ribo-
seq reads were first aligned to a set of known rRNA and tR-
NAs (downloaded from the UCSC RepeatMasker tracks),
followed by alignment of all unmapped reads to the refer-
ence genome. Multi-mapping read were excluded. Feature-
Counts was used to quantify the number of reads per gene
using the Gencode v23 gene models. Only reads aligning to
the sense strand of the gene, represented either by its ex-
ons (RNA-seq) or its coding sequence (Ribo-seq), and with
mapping quality at least 20 were counted. For the paired-
end RNA-seq the additional flags ‘-p -B -C’ was specified
to exclude chimeric reads and/or reads mapping with only
one end.
RNA-seq and Ribo-seq differential expression analyses
Differential expression analysis was done using the R Bio-
conductor edgeR package. Genes with mean expression
below 1 count per million mapped reads were consid-
ered non-expressed and excluded from the analysis. The R
Bioconductor cqn packages (29) was used for conditional
quantile normalization to calculate offsets correcting for
gene lengths (from featureCounts) and GC content (from
biomaRt). The offsets were passed to the edgeR DGEList
object, followed by a likelihood ratio test using glmFit and
glmLRT. Five knockout cell lines (four H9 and two HEK)
were compared to their respective control cell line (two H9
and one HEK). Each cell line was sequenced in four repli-
cates.
Differential translation efficiency (TE) analysis was done
with DESeq2 due to its ability to report the standard er-
ror (SE) associated with each log2 fold change (log2 FC).
First, Nsun6 knockout was compared with control us-
ing the RNA-seq or Ribo-seq data separately to estimate
log2FCs and SEs for each gene and assay. Translational ef-
ficiency of a gene can be defined as the difference between
log2 FCRibo and log2 FCRNA and the associated P-value is
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the probability that this difference is zero. Assuming that
the log2 FCs follow a normal distribution, the T-statistic
was calculated as T = |log2FCRibo−log2FCRNA|√
(SE2Ribo+SE2RNA),
. The resulting
two-tailed P-values were further corrected for multiple test-
ing by false discovery rate correction using the R function
p.adjust.
Determining read periodicity and codon enrichments using
Ribo-seq
Codon usage in the Ribo-seq data was calculated follow-
ing (28). The analysis was focused on reads of length 27–29,
which were showing the strongest periodicity. Position 12–
14 were determined to correspond to the codon at the P-site.
The bam file for each sample with uniquely aligned reads
was converted to bed format. Bedtools intersect was used to
select reads with at least 50% overlap to Gencode-annotated
coding sequences. Next, the reading frame of the 5′ end of
each read was determined using the frame information in
the Gencode annotation. If the frame did not agree with the
expected reading frame for that read length, the read was
discarded. Then, nucleotide positions 1–27 were extracted
from each read as nine codons, numbered as codon posi-
tion –5 to +3, where 0 corresponded to the A-site. As ex-
pected, position –4 to –2 and +1 to +3 correlated well to
the genome-wide distribution of codons in the human trans-
latome, whereas counts from the predicted P-site and A-site
did not.
The number of codon occurrences were counted sepa-
rately for each ribosome-protected codon position and con-
verted into a fraction of the total number of codons. Nor-
malized codon counts were obtained by dividing the codon
fraction at a specific position by the mean fraction across
all nine positions.
Processing and mapping of miCLIP reads
In order to reduce amplification bias, the primers used for
reverse transcription during miCLIP experiments were de-
signed to include a 6-nucleotide random barcode at po-
sitions 1–3 and 8–10 to enable tracing of individual cD-
NAs. Reads were de-multiplexed using the experimental
barcode at positions 4–7, and reads with identical ran-
dom barcodes, representing PCR products, were filtered.
The number of different random barcodes for each unique
read, which represented cDNA counts, was stored for fur-
ther analysis. Barcodes were trimmed from the 5′end, and
the adapter sequence ‘AGATCGGAAGAGCGGTTCAG’
from the 3′end of the reads with cutadapt (https://code.
google.com/p/cutadapt; options: ‘-O 4 –e 0.06’), and only
reads with a minimal length of 18 nt were retained.
Trimmed miCLIP reads were mapped to the human refer-
ence genome (UCSC GRCh37/hg19) by using bowtie (http:
//bowtie-bio.sourceforge.net/index.shtml) with parameters
‘-m1 -v1 –best –strata’ to select uniquely mapping reads
allowing one mismatch. Methylation sites were thus in-
ferred from miCLIP read truncation positions by assign-
ing the read counts to the closest cytosine within ±2nt of
the truncation site. Pooled read counts per cytosine were
normalized per million uniquely mapping reads (RPM). If
not stated otherwise, only high-confidence methylation sites
with normalized read counts >50 RPM in at least two out
of three replicates were selected for down-stream analyses.
Quantifying coding sequence annotation and Ribo/RNA-seq
reads at miCLIP sites
To visualize coding sequence across miCLIP sites, anno-
tated coding sequences (Gencode V28) were merged using
bedtools merge and was then converted to bigWig format
using the UCSC bedGraphToBigWig tool. This was done
separately for both strands. Furthermore, to allow visu-
alization of RNA-seq and Ribo-seq read coverage at mi-
CLIP sites, deepTools bamCoverage was used to convert the
aligned reads to bigWig format. Each strand was quantified
separately, and a blacklist file containing all rRNA, tRNA,
snoRNA, snRNA and miRNA regions was provided. The
bin size was set to 1 and an offset of 12 was used to only
consider a single nucleotide corresponding to the ‘P’ site
predicted from each read.
Next, deepTools computeMatrix in ‘reference-
point’ mode with parameters -b 1500 -a 1500 –
missingDataAsZero’ was used to extract annotation
or reads coverage across miCLIP sites. The Ribo-seq read
coverage was used to classify the miCLIP sites as start,
middle and end of translation, based on the difference
between the number of covered bases up-stream and
down-stream of the miCLIP site. The standard error
(SE) of the differences was calculated and a threshold of
±1.96SE was used to define sites with ‘lower’ or ‘higher’
upstream signal. The remaining sites were classified as
‘unchanged’. Custom R scripts were used to combine sites
on both strands and to visualize it as a heatmap or a profile
plot. The scripts related to this analysis are available at
https://github.com/susbo/Selmi-et-al-scripts.
Calculating overlap between miCLIP sites and differentially
expressed genes
Out of the 15,885 genes expressed in HEK, 1,853 genes
were defined as down-regulated and 2008 as up-regulated
at Padj < 0.05 and abs(log2FC) > 0.5 in both HEK knock-
out clones. Next annovar (30) was used to identify the clos-
est genes for all 252,135 putative miCLIP sites. The set of
genes with exonic miCLIP sites (at 0, 0.5, 1, 3, 5, 10 or 50
RPM) was compared with genes without exonic miCLIP
sites. The relative enrichment or depletion of gene down- or
up-regulation was calculated as an odds ratio with a 95%
confidence interval using Fisher’s exact test.
Processing and mapping of BS-seq reads
The BS-seq was processed as described previously (21).
First, Trim Galore! (v0.4.0) with parameters ‘–stringency 3
-e 0.2 -a TGGAATTCTCGGGTGCCAAGGA’ was used
to remove sequencing adapters and exclude reads shorter
than 20 nucleotides. Next, alignment to the hg38 reference
genome was done using Bismark (v0.14.4) with parameters
‘-n 2 -l 50 –un –ambiguous –bowtie1 –chunkmbs 2048’, to
allow for up to two mismatches and to save unaligned and
ambiguously mapping reads separately. Seqtk with param-
eters ‘-e 3’ was used to remove the last three bases (a poten-
tial tRNA ‘CCA’ tail) from the unaligned and ambiguous
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reads followed by a second alignment attempt using Bis-
mark. Finally, ngsutils (v0.5.9) in the ‘junction’ mode was
used to extract splice junctions from known genes (Gencode
v28) and unaligned reads from the second alignment were
aligned to the junctions using Bismark. Reads aligned to
the junctions were converted back to genomic coordinates
using bamutil (https://github.com/statgen/bamUtil) in ‘con-
vertregion’ mode. ‘N’ in the cigar string was replaced with
‘D’ for compatibility with bismark methylation extractor.
Samtools merge was used to combine aligned reads
from all three alignment attempts. Reads with >1/3
methylated cytosines were discarded as they are likely
artifacts from conversion-resistant regions. The bis-
mark methylation extractor with the ‘–bedGraph –counts
–CX context’ options was used to extract methylated
cytosines.
For comparisons with methylation sites in Huang et al.
(11) we used the published methylation sites from their Sup-
plementary Table S4. The liftover tools was used to convert
hg19 coordinates to hg38 coordinates. However, to visualize
the methylation levels in those samples, we re-aligned those
datasets to the hg38 genome using our pipeline.
To detect tRNA methylation, we downloaded high-
confidence tRNA annotations from GtRNAdb (http://
gtrnadb.ucsc.edu, hg38). Some tRNAs have multiple gene
copies for the same transcript sequence. We selected the
first gene copy (identified by a ‘1’ in the fifth field of its
name, e.g., ‘tRNA-Ala-AGC-9-1’), reducing the number of
tRNA copies from 432 to 261. Next, introns were removed,
the ‘CCA’ tail added, and two flanking ‘N’ on each site of
the transcript was added to avoid Bismark warnings due
to missing sequence context. In order not to exclude multi-
mapping reads during the alignment, a genome index was
prepared for each individual tRNA transcript, followed by
alignment of all reads to all tRNA indices using Bismark
with the parameters described above.
All valid tRNA alignments for each read were extracted.
If a read mapped to multiple transcripts, one alignment
among alignments with the fewest mismatches was selected
at random and the others alignments were discarded. This
ensures that no read is counted multiple times. Reads with
>1/3 methylated cytosines were discarded as they are likely
artifacts from conversion-resistant regions. Finally, the bis-
mark methylation extractor with the ‘–bedGraph –counts
–CX context’ options was used to extract cytosine methy-
lation levels.
Quantification of methylation at miCLIP sites and known
methylation sites
Methylation signal was quantified across protein-coding
miCLIP sites and across the 13 published lists of methy-
lation sites from Huang et al. (11) representing HEK293,
HeLa (control and NSUN2 knockout) and seven tissues.
Genomic coordinates were converted to hg38 using the
liftover tool, and the genomic context (±10 nucleotides) of
the site was extracted. For each set of sites, we analysed sites
with the CTC[CT]A motif and sites without the motif sepa-
rately. To reduce the noise from the miCLIP experiment, mi-
CLIP sites located next to a motif were shifted to the motif
and duplicate sites were removed. For each cytosine within
10 nucleotides from the methylation site, the total number
of reads that either supported or did not support methy-
lation were calculated. To avoid having very high-covered
sites dominating the analysis, sites with more than 5 reads
were normalized to 5 reads before the reads were summa-
rized. Methylation level was calculated as the number of
normalized reads supporting methylation, divided by the
total number of normalized reads.
Analysis related to translation readthrough
To determine if miCLIP sites in 3′ UTRs of protein cod-
ing genes (n = 522) could be associated to translation
readthrough, we determined the frequency of in-frame
stop codons between the nearest up-stream annotated stop
codon and the 3′ UTR miCLIP site. As a control, we used
a region of equal size immediately down-stream of the mi-
CLIP site.
Translational readthrough is associated with usage or
rare stop codons and unfavoured stop codon contexts, de-
fined as the base immediately down-stream of the stop
codon. The stop codon context for all annotated stop
codons (Gencode V23) was retrieved using samtools faidx.
Genes with multiple annotated stop codons were repre-
sented as a fraction of stop codons with sum 1. The over-
all stop codon context was calculated for all protein-coding
genes or those that were identified as miCLIP targets, re-
spectively.
RESULTS
miCLIP reveals enzymatic targets of NSUN6
RNA:m5C methyltransferases contain a catalytic domain
with a common structural core and the S-Adenosyl
methionine-binding site (Supplementary Figure S1A). Two
conserved cysteines, both located within the methyltrans-
ferases active site, are required for completion of the cat-
alytic process (31). Methylation is initiated when cysteine
(C1) forms a covalent bond with the cytosine pyrimidine
ring (32). The second conserved cysteine (C2) is required to
then break the covalent adduct and to release the methy-
lated RNA (Supplementary Figure S1B). Mutating C2 to
alanine results in the irreversible formation of an enzyme-
RNA crosslinked complex precisely at the methylated cy-
tosine (Supplementary Figure S1C) (31,33,34). The cross-
linked site can then be directly identified without further fix-
ation steps during the immunoprecipitation protocol, omit-
ting unspecific RNA-protein events (12,22). Because the
crosslinking occurs during the methylation reaction, we
termed the method methylation iCLIP (miCLIP) (12).
We previously utilized miCLIP to identify NSUN2 and
NSUN3 methylated nucleosides transcriptome-wide (Fig-
ure 1A; Supplementary Figure S1A-C) (12,17). Here, we
analysed a third related m5C RNA methyltransferase,
NSUN6. We sequenced all RNAs crosslinked to the mu-
tated NSUN6 protein (Figure 1B) and found that the major-
ity of miCLIP sites located to mRNAs (Figure 1C; Supple-
mentary Table S1). In contrast to NSUN6, NSUN2-specific
miCLIP sites mainly occurred in tRNAs (Figure 1D; Sup-
plementary Table S2) (12). NSUN2 and NSUN6 shared less
than 4% of identified miCLIP targets (Supplementary Fig-
ure S1D), and the vast majority of shared sites in mRNAs
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Figure 1. NSUN6 miCLIP reveals consensus motif in targeted RNA. (A) Schematic overview of the miCLIP method. (B) Polyacrylamide gel showing
NSUN6-tagged proteins and released RNA after RNase treatment, which was isolated and sequenced. C2A: construct carrying the point mutations
C→A; WT: wild-type construct. (C, D) Number of NSUN6 (C) and NSUN2 (D) miCLIP sites in the indicated RNAs. (E) Number of NSUN6 miCLIP
sites in protein coding RNAs. (F) Distribution of NSUN6 miCLIP sites along mRNA. (G) Number of detected NSUN6 miCLIP sites within 50 nucleotides
windows in a total of 1279 RNAs. (H, I) Binding motifs (upper panels) of NSUN2 (H) and NSUN6 (I) and frequency of miCLIP sites at the respective
position (lower panels). (J) Illustration of structural motifs analysed by GraphProt. (K) Identified sequence (upper panel) and structural motif (lower
panel) of NSUN6-targeted sites. (L) Examples of hairpin loop structures in NSUN6-targeted mRNAs. Me: methylation. (M) Overlap of predicted (grey)
and observed (blue) miCLIP sites containing the sequence structure motif in the HEK transcriptome.
located to non-coding RNAs or untranslated regions (Sup-
plementary Figure S1E). Thus, NSUN6 has a distinct sub-
strate specificity, different from NSUN2.
NSUN6 targets 3′ UTRs in a sequence- and structure-specific
manner
We previously identified that a small number of NSUN2-
specific miCLIP sites in mRNAs which mostly occurred in
introns of nuclear-encoded genes (Supplementary Figure
S1F) (12). In contrast, NSUN6-mediated methylation oc-
curred mainly in the 3′UTR (Figure 1E, F). The advantage
of miCLIP over other RNA immunoprecipitation meth-
ods is the covalent cross-link of the enzyme to the cytosine
undergoing methylation, allowing the detection of the en-
zymatic reaction at nucleotide-resolution (12,22). Accord-
ingly, we found that NSUN6-specific target sites predomi-
nantly occurred as single sites (Figure 1G).
Only NSUN6-targeted sites occurred in a sequence-
specific manner, and the consensus sequence motif was
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present in the vast majority (80%) of all targeted sites (Fig-
ure 1H, I; Supplementary Figure S1G). Since RNA sec-
ondary structures can modulate protein binding (35), we
asked whether local RNA structure influenced NSUN6 tar-
geting. We determined the sequence- and structure-specific
preferences of NSUN6 miCLIP sites using GraphProt (Fig-
ure 1J) (36), and found that the methylated sites occurred
preferentially centred within hairpin loops (H) of stem
loop structures (Figure 1K, L). The fraction of predicted
structural motifs was independent of the miCLIP thresh-
old (10–50 RPM) (Supplementary Figure S1H). Our data
is consistent with a previous study showing that NSUN2-
independent methylation sites in mRNAs located to stem
loop structures (11).
Finally, we asked what fraction of mRNAs contained a
NSUN6-targeted sequence-structure element (Supplemen-
tary Figure S1I). First, we calculated that the minimum
free energy of NSUN6-targeted RNA sequences to form a
stem loop was –5 kcal/mol (Supplementary Figure S1J),
and 47% of all miCLIP sites formed a stem loop under
this condition (Supplementary Figure S1J). Then, we com-
pared the predicted with the observed number of NSUN6-
targeted sites in the transcriptome, and found that ∼14% of
all predicted sites in mRNAs were also targeted by NSUN6
(Figure 1M).
In conclusion, mRNA targeting by NSUN6 is based on
a defined sequence-structure element in mRNAs.
RNA bisulfite sequencing confirms NSUN6-specific methyla-
tion and consensus motif
The miCLIP method relies on over-expressing the mu-
tated protein (37). To confirm endogenous NSUN6-specific
methylation sites, we performed RNA bisulfite (BS) se-
quencing (BS-seq) (25,38). BS-seq on mRNAs remains
challenging due to high RNA degradation during the pro-
tocol resulting in low mRNA coverage (39). To increase
the confidence in all discovered sites, we used two indepen-
dent cell lines, the human embryonic cell lines Hues9 (H9)
and HEK293 (HEK). As negative controls, we generated at
least two independent knockout clones via CRISPR/Cas9
genome editing for each cell line (Supplementary Figure
S2A). Furthermore, we over-expressed NSUN6 in two inde-
pendent H9 clones, and rescued two HEK knockout clones
by stably over-expressing the NSUN6 construct (Supple-
mentary Figure S2A). At least four replicates from each
condition were subjected to the BS conversion protocol,
generating a total of 68 RNA BS-seq datasets (Supplemen-
tary Figure S2A). For the analyses of the RNA BS-seq data
we used our established pipeline (Figure 2A; Supplemen-
tary Table S3) (https://github.com/susbo/trans-bsseq) (21).
After mapping the reads (Figure 2B), all technical repli-
cates were pooled to achieve the highest number of reads
per cytosine in each condition. In summary, we analysed
the following conditions: (i) NSUN6 knockout (KO) cells
(n = 28), (ii) wild-type (WT) cells with endogenous expres-
sion of NSUN6 (n = 24), (iii) NSUN6 rescued (RES) cells
(n = 8) and (iv) NSUN6 over-expressing (OEX) cells (n =
8) (Supplementary Figure S2B–E).
Next, we used the BS-seq data to evaluate the miCLIP
sites, focusing on predicted sites with the sequence motif
and located in protein-coding genes. As expected, the over-
all methylation and mRNA read coverage was often low
(Supplementary Table S4). Nonetheless, the BS-seq datasets
covered about 20% of miCLIP sites (Figure 2C; Supplemen-
tary Table S4). The total number of m5C sites detected by
both methods correlated well with expression of NSUN6
(Figure 2D). The vast majority of m5C sites (∼80%) de-
tected by both methods depended on NSUN6 in both cell
lines (Figure 2E; Supplementary Table S4). Furthermore,
the NSUN6-targeted RNAs substantially overlapped in the
two cell lines (Figure 2F). Together, our BS-seq analysis
reliably detected endogenous NSUN6-specific methylation
sites in the transcriptome, but strongly relied on RNA abun-
dance and methylation level at the specific cytosines.
To further confirm endogenous methylation of NSUN6-
specific sites we performed mass spectrometry analysis. We
revealed that only deletion of NSUN6 simultaneously with
NSUN2 and DNMT2 resulted in a detectable reduction
of m5C levels in tRNAs and large RNAs (Supplementary
Figure S2F, G). Nevertheless, m5C levels were highest in
NSUN6-rescued HEK cells in purified mRNA, but m5C
levels in 18S rRNA was unaffected (Figure 2G). Other
mRNA modifications (m6A and m7G) did not consistently
change (Supplementary Figure S2H). Thus, the mass spec-
trometry analyses confirmed that NSUN6-dependent m5C
sites in mRNA were present at low stoichiometry.
Next, we asked whether BS-seq confirmed the consen-
sus motif CTCCA. All of the top seven RNAs identified
by BS-seq containing NSUN6-mediated m5C sites, con-
tained the CTCCA motif (Figure 2H; Supplementary Table
S5). One of these sites located to tRNAThr (ACG), a previ-
ously known NSUN6-target (20). In this case, the motif was
only present when taking CCA-editing of tRNAs into ac-
count (Figure 2H) (40). Since our analyses excluded multi-
mapping reads (Figure 2A), we obtained poor read coverage
over many tRNAs. tRNAs have low sequence uniqueness
and therefore, they were not detected in our global anal-
ysis. To confirm that we can identify all known NSUN6-
mediated methylation sites in tRNAs, we re-aligned our
data to all tRNA genes. In this analysis, we allowed for
multi-mappers. In addition to tRNAThr (ACG), we confirm
tRNAThr (TGT), (CGT), (AGT) and tRNACys (GCA) to be
specifically methylated by NSUN6 (Figure 2I, J) (20). No
other NSUN6-dependent m5C sites were found in tRNAs.
In conclusion, three independent methods identify
NSUN6-dependent methylation in mRNA. However, in
line with previous studies the overall number of m5C was
low and single sites having methylation levels of >20% were
extremely rare (8).
NSUN6-specific methylation strictly depends on the consen-
sus sequence
Since NSUN6 mainly targeted mRNAs (Figure 1C), we
next focused on miCLIP sites within protein coding re-
gions. As those miCLIP sites were covered by compara-
bly few reads in the BS-seq data (Figure 3A), we extended
our analysis by asking which NSUN6 miCLIP sites were
also identified in previously published datasets (Supplemen-
tary Table S4) (11,13). The miCLIP sites consistently over-
lapped with known m5C sites across 13 different cell lines
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Figure 2. BS-sequencing confirms NSUN6 methylation sites. (A) Pipeline of data analyses using BS-sequencing data. (B) Summary of all mapped reads in
the different conditions (left panel). WT: Wild-type; KO: knockout; RES: Rescue of NSUN6. Total number of mapped reads (right panel). (C) Overlap of
miCLIP sites with m5C sites detected by BS-seq in H9 and HEK cells. (D) Methylated sites identified by miCLIP and BS-seq in the indicated conditions
in HEK and H9 cells. (E) m5C sites identified by miCLIP and BS-seq (dark blue) in H9 (left panel) and HEK (right panel) cells. (F) Overlap of RNAs
containing m5C sites detected by both miCLIP and by BS-seq in H9 and HEK cells. (G) Quantification of m5C in purified mRNA (left panel) and 18S
rRNA (right panel) by mass spectrometry in the indicated HEK samples. (H) NSUN6-dependent methylation sites identified by only BS-seq in H9 and
HEK cells. Red: CTCCA consensus motif. (I) Heatmaps of tRNA Thr and Cys isotypes carrying NSUN6-mediated methylation sites (red; star). (J)
Quantification of (I) showing average methylation levels in the indicated samples.
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Figure 3. Methylation at NSUN6 consensus sequence. (A) Number of protein coding miCLIP sites and coverage of BS-seq reads. (B) Fraction of methy-
lation sites identified in the indicated datasets overlapping with NSUN6 miCLIP sites. (C) NSUN6-targeted sites with confirmed m5C in more than 5 out
of 14 different datasets. (D–H) Representative heatmaps showing the methylation levels in the indicated selected mRNAs (D-G), tRNAThr (CGT) as a
control (H). (I) NSUN6-dependent methylation around the consensus sequence. (J, K) Mean methylation levels in knockout (KO), wild-type (WT), and
NSUN6-overexpressing (OEX) cells at 994 miCLIP sites containing the consensus motif (J), and 275 sites without the consensus motif (K). Shown are
biological replicates in H9 and HEK cells. (L–O) Methylation levels at published m5C sites (11) containing the consensus motif identified in all datasets
(L) or in selected tissues of frontal cortex (M) and testis (N), or lacking the motif (O). (P, Q) Illustration of the luciferase reporter containing the Angel1
3′UTR and transfection into two NSUN6 HEK knockout clones (KO1, KO2) and one rescued KO clone re-expressing NSUN6 (P), or co-transfection with
constructs expression the wild-type (wt) or methylation-deficient (mut) NSUN6 protein in HEK KO1 (Q). (R) Luciferase reporter assay using constructs
shown in (P). (S) Luciferase reporter assay using constructs shown in (Q). ****padj < 0.0001; ***Padj < 0.001; *Padj < 0.05. one-way ANOVA (R,S). (T)
RT-QPCR for selected mRNAs carrying NSUN6-methylated cytosine in control, knockout (KO) and over-expressing (OEX) H9 cells. Data are normalized
to 18S rRNA and shown relative to control cells. Outlier (highest and lowest values) are removed. **Padj < 0.01; *Padj < 0.05. Two-way ANOVA (all data
points).
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and tissues, and the greatest overlap was found in NSUN2-
knockout cells (Figure 3B). Thus, many of the NSUN6-
dependent miCLIP sites were confirmed to be methylated
in a wide range of biological conditions (Figure 3C). For in-
stance, the m5C site found in translocase of inner mitochon-
drial membrane 50 (TIMM50) was the most commonly
detected NSUN6-specific site and present in 13 out of 14
datasets, including our study (Figure 3C; Supplementary
Table S4). As expected, the methylation levels of NSUN6-
targeted mRNA varied between conditions, but was often
supported by multiple additional datasets (Figure 3D–H;
Supplementary Figure S3A). Thus, NSUN6 miCLIP reli-
ably detected m5C in the transcriptome.
Next, we asked whether the consensus motif was im-
portant for NSUN6-specific methylation. NSUN6 miCLIP
sites containing the motif CTC[CT]A lacked m5C in knock-
out cells, but showed enhanced methylation levels in wild-
type and over-expressing cells (Figure 3I, J; Supplemen-
tary Table S6). miCLIP sites without the consensus mo-
tif displayed constant methylation levels, independent of
NSUN6-expression (Figure 3K).
To further confirm that only CTC[CT]A-containing
methylation sites depended on NSUN6, we analysed methy-
lation levels in our BS-seq data across all previously identi-
fied m5C sites (Supplementary Table S7) (11,13). The level
of methylation across published m5C sites also strongly
correlated with expression of NSUN6, but only when the
NSUN6-target motif was present (Figure 3L–O). We ob-
tained the same results when using all identified m5C sites
or only those detected in frontal cortex and testis (Figure
3L–O).
In conclusion, NSUN6-specific methylation of mRNA is
widely present in published datasets and strictly depended
on the consensus sequence motif.
NSUN6-targeting enhances mRNA abundance and transla-
tion
To test how NSUN6 affected the targeted mRNAs, we
cloned the 3′ UTR of Angel1 into a luciferase reporter con-
struct. First, we expressed the reporter in NSUN6 knock-
out (KO) and rescued (RES) HEK clones (Figure 3P). Sec-
ond, we co-transfected the reporter with constructs express-
ing either the wild-type (wt) or methylation-deficient mu-
tant (mut) NSUN6 protein (Figure 3Q). The reporter ac-
tivity was significantly higher when NSUN6 was present
(Figure 3R). Next, we asked whether the methylation ac-
tivity was required to enhance the reporter activity. Re-
expression of the wild-type (wt) NSUN6 protein signifi-
cantly up-regulated the reporter activity when compared
to the mutated (mut) NSUN6 protein (Figure 3S). Thus,
NSUN6-dependent methylation enhanced the reporter ac-
tivity.
To further characterize the effect of NSUN6-dependent
methylation on endogenous mRNA levels, we measured the
level of m5C containing mRNAs in the absence and pres-
ence of NSUN6 (Figure 3T; Supplementary Figure S3B).
In both knockout cell lines, mRNA levels were reduced in
the absence of NSUN6, but reversed to normal levels when
NSUN6 expression was restored (Figure 3T; Supplemen-
tary Figure S3B), suggesting that NSUN6-mediated methy-
lation directly or indirectly enhanced mRNA levels.
To test whether NSUN6-targeted mRNAs shared com-
mon functions, we identified enriched gene ontology (GO)
terms in all protein coding RNAs containing a miCLIP
site (n = 906; Supplementary Table S4). NSUN6-targeted
mRNAs mostly encoded for RNA- and protein-binding
proteins, indicating a role in regulating gene expression
(Figure 4A). Most NSUN6 miCLIP targets were down-
regulated in knockout cells in RNA-seq experiments (Fig-
ure 4B, C; Supplementary Figure S4A–C; Supplementary
Table S8). This was highly significant in HEK cells, where
an mRNA with miCLIP sites were 5-fold more likely to
be down-regulated compared with mRNAs without mi-
CLIP sites (Supplementary Figure S4D). Repressed mR-
NAs encoded proteins involved in both RNA processing
and translation, such as the polyadenylate-binding proteins
PABPC1 and PABPN1 and the translation initiation factors
EIF4G1 and EIF1 (Figure 4D, E). Thus, our data identify
a function for NSUN6-targeted mRNAs in regulating post-
transcriptional and translational processes (Supplementary
Figure S4E). Transcriptional profiling of NSUN6-depleted
HEK and H9 cells confirmed that genes encoding for RNA-
binding proteins, and in particular of pre-mRNA and 3′
UTR, were significantly repressed (Supplementary Figure
S4F–H; Supplementary Table S8).
Since NSUN6 mostly methylated 3′ UTRs, we specu-
lated that deposition of m5C regulated mRNA translation.
To test for translation differences, we performed ribosome
profiling in wild-type and knockout H9 cells (Supplemen-
tary Table S9) (41). We confirmed that ribosome occu-
pancy of NSUN6 targeted mRNAs was lower in the absence
of NSUN6 (Figure 4F, blue dots; Supplementary Figure
S4I; Supplementary Table S9). Since ribosome occupancy
cannot distinguish between altered mRNA abundance or
higher coverage of ribosomes per mRNA, we next calcu-
lated translation efficiencies. The translation efficiency of
most NSUN6-targeted mRNAs was repressed (Figure 4G,
blue dots; Supplementary Figure S4J; Supplementary Ta-
ble S9). However, global protein synthesis was not signif-
icantly affected by depletion of NSUN6 (Supplementary
Figure S4K). Again, inhibition of translation primarily af-
fected RNA- and protein-binding factors involved in regu-
lating mRNA processing and translation (Figure 4H). Thus,
our data indicated that NSUN6 regulated gene expression
on the post-transcriptional and translational level.
NSUN6-targeted CTCCA motifs mark translation termina-
tion sites
To determine how NSUN6-dependent methylation affected
mRNA translation, we calculated the ribosome occupancy
around miCLIP sites in mRNAs containing the CTCCA
motif (n = 994) (Figure 5A). The ribosome footprints dis-
played a strong bias towards only one side of the CTCCA
motif. Therefore, we grouped the ribosomes occupancies
into (a) lower, (b) unchanged or (c) higher up-stream of the
NSUN6 miCLIP site (Figure 5A,B). The majority of mR-
NAs had higher ribosome occupancies up-stream of the mi-
CLIP site (Figure 5B,C), which was expected because most
miCLIP sites localized to 3′ UTRs (Figure 5D). The differ-
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Figure 4. NSUN6-targeted RNAs regulate RNA processing and translation. (A) Gene Ontology (GO) analysis (molecular function) of all NSUN6-targeted
protein coding RNAs in HEK cells using GOrilla (http://cbl-gorilla.cs.technion.ac.il/). Background: All expressed genes in HEK cells. (B) Log2 fold-change
(FC) expression of all miCLIP targets. Orange dots: miCLIP targets belonging to the GO category ‘RNA-binding’ (GO: 0003723). Blue dots: All other
miCLIP targets. (C) Cumulative fraction of log2 fold-change (FC) expression levels of all miCLIP targets (blue) compared to all other protein coding genes.
P-value was calculated using the Kolmogorov-Smirnov test. (D, E) Examples of top up- (red) and down-regulated (blue) mRNAs targeted by NSUN6 in
HEK (D) and H9 cells (E) when NSUN6 is depleted. (F, G) Ribosome occupancy (F) and translation efficiency (G) (illustration, left panels) of all ribosome
covered mRNAs (grey) and miCLIP targets (blue) in wild-type (WT) versus NSUN6 knockout (KO) H9 cells. (H) Gene Ontology analysis of mRNAs with
significantly (padj<0.05) changed translation efficiency.
ence in ribosome occupancy at miCLIP sites was indepen-
dent of mRNA levels (Supplementary Figure S5A).
Moreover, the sharp drop in ribosome occupancy shortly
after the miCLIP site in group (c), suggested translation
termination. To further explore the idea that NSUN6-
targeted CTCCA motifs marked translation termination,
we measured the level of annotated protein coding se-
quences around the miCLIP site in groups (a), (b) and (c)
(Figure 5E). We were surprised to see protein coding se-
quences directly abutting miCLIP sites in group (c), because
most of those miCLIP sites overlapped with non-coding
3′UTRs (Figure 5D; Supplementary Figure S5B). To con-
firm this result, we repeated the analyses only considering
3′ UTR miCLIP sites (Figure 5F), revealing a significant
enrichment of coding sequences up-stream of the miCLIP
site, followed by a sharp drop thereafter (Figure 5G). As a
control we used randomly selected 3′ UTR CTCCA sites
(Figure 5G).
The absence of ribosome footprints directly after the mi-
CLIP sites suggested stalling or removal of ribosomes. Be-
cause the miCLIP consensus sequence does not cover stop
codons (Figure 1I), we asked where stop codons were po-
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Figure 5. NSUN6 miCLIP sites with CTCCA consensus motif mark translation termination. (A) Illustration of the Ribo-seq data analysis. (B) Number
of miCLIP sites with ribosome occupancy shown in (A). (C) Heatmaps of Ribo-seq reads around the miCLIP sites in NSUN6 knockout (KO) and control
cells (shown are two representative replicates each). Arrowheads indicate position 0 of miCLIP sites. (D) Percentages of miCLIP sites located in the CDS,
5′ and 3′ UTRs in the indicated groups (a–c) (E) Fraction of annotated protein coding sequences with (a) lower (upper panel), (b) unchanged (middle
panel), or (c) higher (lower panel) number of reads before the miCLIP sites. (F, G) Illustration (E) and quantification (G) of annotated CDS around 509
miCLIP or randomly selected motif sites in 3′ UTRs. The random selection was repeated 1000 times and the mean and confidence interval are shown. (H,
I) Illustration (H) and quantification (I) of annotated stop codons around 509 miCLIP or randomly selected sites in 3′ UTRs. Random selection repeated
as for (G). (J) Codon enrichment in NSUN6 knockout cells versus control cells at the indicated positions of the ribosomes’ active sites. Stop codons are
marked red. Codons requiring NSUN6-methylated tRNAs are marked in blue and green. (K) Illustration of codon usage analyses covering the miCLIP
consensus sequence (CTCCA). (L–N) Normalized read coverage with CTCCA at the indicated position of the ribosome footprint (N) with calculated
significance levels (M) and illustration of codon positions at tRNAs at the P- and E-sites (N).
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sitioned relative to the miCLIP sites (Figure 5H). We find
annotated stop codons significantly enriched in close prox-
imity to, but mostly up-stream of, miCLIP sites (Figure 5I).
Together, our data revealed that NSUN6-targeted CTCCA
sites marked translation termination.
To explore whether NSUN6 was involved in regulating
translation termination, we evaluated whether depletion of
NSUN6 resulted in stop codon biases during mRNA trans-
lation. When we calculated the codon frequencies at the ri-
bosome active sites (E, P, A) we found stop codons were
enriched at the ribosomal P-site in the absence of NSUN6
(Figure 5J). As the presence of a stop codon at the ribo-
some A-site is generally the signal to terminate protein syn-
thesis, our data indicated altered translation termination in
NSUN6-depleted cells. In contrast, we found no differences
in codon usage for the NSUN6-methylated tRNAs Thr and
Cys in NSUN6-depleted cells (Figure 5J).
Together, our data indicated that NSUN6-targeted
CTCCA sites marked translation termination, even when
these sites occurred in the 3′ UTRs (Supplementary Figure
S5B). Detecting translation events in the 3′ UTR suggests
that the ribosome has read through stop codons in these
specific transcripts. While ribosome-profiling experiments
commonly uncover stop-codon read-through (42–44), it is
a very rare event (0.02% to 1.4%), and largely caused by
incidental cellular errors during translation (42,43,45,46).
Moreover, the rate of transcriptional read-through often de-
pends on specific stop codons and their flanking sequences
(47). While NSUN6-targeted mRNAs were not consistently
enriched for specific stop codons (Supplementary Figure
S5C), we measured slightly fewer alternative stops between
the annotated stop and the miCLIP site when compared
to nearby control sequences of the same lengths (Supple-
mentary Figure S5D). Thus, our data suggested a potential
role of NSUN6 in promoting translation fidelity by ensur-
ing translation termination at targeted mRNAs.
To test whether NSUN6 methylation contributed to
translation fidelity, we measured ribosome occupancies at
CTCCA motifs (Figure 5K). In the presence of NSUN6,
we found that m5CTCCA motifs appeared significant less
often at positions 11 and 14 of the E- and P-binding sites
for tRNA in the ribosome (Figure 5K–M). In these cases,
the corresponding ‘CCA’ bases of the motif occupy the ri-
bosome A- or P-site respectively (Figure 5L). Since ‘CCA’
encodes for proline, we confirmed that proline codons were
significantly enriched at the ribosome A-site (Supplemen-
tary Figure S5E; Supplementary Table S10).
In conclusion, mRNAs with the codon sequence (N-
m5C-T) followed by (C–C–A) spent less time at the ribo-
somes’ P- and E-site in the presence of NSUN6, possibly
due to a faster removal of the ribosome (Figure 5N).
NSUN6 is dispensable for development but might be a prog-
nostic marker in cancer
Knockout of NSUN6 in H9 and HEK cells did not cause
any apparent cellular phenotype. Since RNA modification
enzymes often act directly in response to external stim-
uli (2), we asked whether differentiation of human embry-
onic stem cells was affected when NSUN6 was depleted.
We differentiated the H9 cells into embryoid bodies and
confirmed reduced levels of NSUN6-targeted mRNAs in
embryoid bodies lacking NSUN6 (Supplementary Figure
S6A). While pluripotency factors were not differentially ex-
pressed, some mesoderm markers and Hoxa1 were consis-
tently reduced in the absence of NSUN6 (Supplementary
Figure S6B). Finally, we asked whether loss of NSUN6 af-
fected embryonic development. To generate total knock-
out mice, we used two embryonic stem cell clones carry-
ing the LacZ-reporter in exon 2 of the Nsun6 gene leading
to transcriptional disruption of a functional NSUN6 pro-
tein (Supplementary Figure S6C). Although LacZ expres-
sion revealed that Nsun6 was quite ubiquitously expressed,
we observed no gross phenotype in the absence of NSUN6
(Supplementary Figure S6D). We concluded that mouse
embryonic development was largely unaffected by total loss
of NSUN6.
To identify other potential cellular functions of NSUN6,
we compared Nsun6 expression levels in human tissues col-
lated in the Genotype-Tissue Expression (GTEx) database
(Figure 6A). Nsun6 was ubiquitously expressed with highest
levels found in testis and lowest expression in blood (Figure
6A). When we analysed tumours derived from tissues with
high or low Nsun6-expression, we found Nsun6 mRNA lev-
els to be down-regulated in tumours, but only when derived
from high Nsun6-expressing tissues (Figure 6B; upper pan-
els). Nsun6 was significantly down-regulated in tumours de-
rived from testis, thyroid and ovaries. In contrast, we found
no difference in RNA levels when the tumours derived from
low-expressing tissues, such as blood, kidney or pancreas
(Figure 6B; lower panels).
In line with our finding that Nsun6 was higher expressed
in normal liver than liver tumours (Figure 6B, upper panel),
over-expression of NSUN6 has recently been shown to in-
hibit cell proliferation of liver cancer cells (48). Cell prolif-
eration and migration are often reciprocally controlled (49),
and we find that NSUN6-expression enhanced migration
in cancer cells (Figure 6C, D; Supplementary Figure S6E).
However, Nsun6-expression was also significantly lower in
later pathological stages of tumours derived from high ex-
pressing tissues (Figure 6B, upper panel; Figure 6E), and
correlated with better patient survival (Figure 6F). Thus,
NSUN6 might be a novel biomarker for positive patient
outcome in cancers derived from testis, ovary, thyroid, liver
and brain.
In summary, here we identify NSUN6 as a methyltrans-
ferase strictly targeting mRNAs at a consensus sequence
motif near non-canonical translation termination sites.
Loss of NSUN6-mediated methylation decreased mRNA
levels and reduced translation. NSUN6 was not required
for embryonic development. However, NSUN6 was down-
regulated in at least some cancers and might be a novel
biomarker predicting patient outcome.
DISCUSSION
RNA modifications add flexibility, diversity and complex-
ity to cell type and state-specific gene expression programs.
Mapping these RNA modifications on single nucleotide res-
olution is a critical step towards understanding the under-
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Figure 6. NSUN6 as a putative predictive biomarker in cancer. (A) Nsun6 RNA expression levels in adult human tissues (https://www.gtexportal.org/
home/). (B) Nsun6 RNA expression levels in tumours derived from high (upper panel) and low (lower panel) Nsun6 expressing tissues shown in (A)
(http://gepia.cancer-pku.cn/). (C, D) Knock-down of NSUN6 (C) and migration assay (D) of cancer cells (MBA-MD-231). * P-value < 0.05. Unpaired
t-test. (E, F) Stage plot (E) and survival plot (F) of Nsun6-low expressing cancers shown in (B; upper panel).
lying regulatory pathways. Despite recent advances in tech-
nologies to detect RNA modifications in mRNAs (3,50–
52), the prevalence and precise location of in particular
low abundance modifications remain often unclear (9). Al-
though the need for more robust detection methods was
recognised very early in the field (53), RNA BS-seq remains
the method of choice for mapping m5C transcriptome-wide
because it is currently the only available method detecting
m5C sites on endogenous mRNAs in a quantitative manner
(39).
Optimizing RNA BS-seq protocols and computational
analyses is one strategy to improve the detection of m5C
(8,11). The most recent study identified about 100 m5C sites
per mega base in a given mammalian tissue or cell type (11).
Huang et al. (11) further demonstrated that many but not all
detected sites were NSUN2-dependent, and that NSUN2-
independent sites were marked by a 3′TCCA motif. The au-
thors suggested that this sequence motif was targeted by an
uncharacterised cytosine-5 RNA methyltransferase (11). In
our study, we discover the same consensus motif (CTCCA)
in mRNAs and further demonstrate that it is in fact targeted
by the characterised cytosine-5 methyltransferase NSUN6.
Together, our data implicate a role for NSUN6-
methylation in regulating translation termination. The pres-
ence of the methyl group at CTCCA motifs in protein
coding RNA correlated with greater RNA abundance
and translation, while the motif itself was enriched in 3′
UTRs near sites of translation termination down-stream
of annotated stop codons. Ribosome profiling further re-
vealed an enrichment of stop codons at the ribosome P-
site in NSUN6-depleted cells. Given that ribosome foot-
prints occurred mostly up-stream, but rarely down-stream,
of miCLIP sites including in 3′ UTRs, NSUN6-dependent
methylation might be part of quality control mechanisms
ensuring termination of translation, possibly after stop
codon read-through. The low levels of stop codon read-
through may explain why the percentage of methylation is
low in most NSUN6-targeted mRNAs. Our data further in-
dicate a potential function of NSUN6 in translation termi-
nation fidelity of primarily RNA and protein-binding pro-
teins in adult tissues of testis, ovaries and liver for example.
Our finding that targeted mRNAs are more abundant in the
presence of m5C is in line with the recent finding that m5C
protects maternal mRNA from decay in the maternal-to-
zygotic transition (54).
We find that most of m5C sites in the protein coding
RNAs are catalysed by NSUN6. Our observation that the
majority of such sites occur at low stoichiometry is one ex-
planation why the prevalence of m5C in mRNAs has pre-
viously been controversial. Furthermore, the low methyla-
tion levels of mRNAs hampers studying the functional rel-
evance of m5C, and may also explain the apparent lack of
any gross phenotype in NSUN6-depleted mice. However,
NSUN6 may confer cellular fitness advantages in specific
environmental context, as we find NSUN6 to be higher ex-
pressed in healthy tissues than in tumours.
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